The president and executive medical director of Washington Permanente Medical Group stressed distribution simulations and constant communications as key factors to efficient vaccine rollout.
Peter Barkett, MD, an internist with Washington Permanente Medical Group, examines the history of vaccines and how they are powerful tools to promote public health.
Paul Minardi, MD, president and executive medical director of Washington Permanente Medical Group, surveys the history of pandemics and finds that infectious disease outbreaks have driven transformation and innovation in public health.
David Grossman, MD, of Washington Permanente Medical Group, and Eric Larson, MD, of Kaiser Permanente Washington Health Research Institute, published a peer-reviewed viewpoint in JAMA about the potentially powerful implications of population genomics for the future of health care.
A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.
In a recent article by The Wall Street Journal, Eric Larson, MD, a physician with Washington Permanente Medical Group and senior investigator for the Kaiser Permanente Washington Health Research Institute, is quoted about dementia prevention research published in a report commissioned by the Lancet medical journal.
As part of a growing partnership, Permanente physicians are working to provide world-class care for Special Olympics athletes across multiple specialties.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.